B4GALNT1 and neoplasm: Increased protein levels of B4GALNT1 in tumor tissues were also observed in Western Blot (WB) tests on 21 patients (Fig. 1c and Fig. S1) and immunohistochemistry (IHC) assays on 93 other patients (p < 0.001) (Fig. 1d and e).